IFNB in MS

Neurology

Volumn 47, Issue 4, 1996, Pages 1110-1112

  Rolak, L A ^a   Barnes, D ^a   Milanese, C ^a   Savettieri, G ^a   Terzian, E ^a   Sibley, W A ^a   Paty, D ^a   Ebers, G ^a   Reder, A ^a   Lublin, F ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON BETA SERINE; BETA INTERFERON;

CLINICAL TRIAL; DRUG COST; DRUG EFFICACY; DRUG MECHANISM; HUMAN; HUMAN CELL; HUMAN TISSUE; LETTER; MEDICAL RESEARCH; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PRIORITY JOURNAL; TREATMENT OUTCOME; NOTE; PATHOPHYSIOLOGY; PROGNOSIS;

HUMANS; INTERFERON-BETA; MULTIPLE SCLEROSIS; PROGNOSIS;

EID: 0029805038     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.47.4.1110     Document Type: Letter

References (0)